A novel method for removing residual acetone from gelatin microspheres

被引:3
作者
Wang, W [1 ]
Antonsen, K [1 ]
Nayar, R [1 ]
机构
[1] Bayer Corp, Biotechnol, Berkeley, CA 94701 USA
关键词
acetone; gelatin microsphere; glass transition; moisture; residual solvent removal;
D O I
10.1081/PDT-120003485
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. To develop a method for removing residual acetone from gelatin microspheres. Methods. Free-flowing gelatin microspheres were either heated under vacuum or subjected to a stream of humidified air in a specially designed apparatus for removal of the residual acetone. To understand the removal mechanism, hygroscopic and thermal properties of the microspheres were examined. Results. Heating the gelatin microspheres under vacuum did not reduce the acetone level below 2%, but the use of humidified air under fluidizing condition reduced the residual acetone in gelatin microspheres by an additional two orders of magnitude. The rate of acetone removal was a strong function of the relative humidity (RH) of the air stream; higher RH accelerated acetone removal. Other variables influencing the acetone removal rate are the mean particle diameter and the linear velocity of the humidified air. Under high relative humidities, significant amounts of moisture were absorbed into gelatin microspheres, reducing their glass transition temperature below 25degreesC. Conclusion. The residual acetone in gelatin microspheres can be efficiently removed when exposed to air of high RH. Mechanisms of water-dependent acetone removal are proposed.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 23 条
[1]   The delivery of angiogenic factors to the heart by microsphere therapy [J].
Arras, M ;
Mollnau, H ;
Strasser, R ;
Wenz, R ;
Ito, WD ;
Schaper, J ;
Schaper, W .
NATURE BIOTECHNOLOGY, 1998, 16 (02) :159-162
[2]   Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages [J].
Barrow, ELW ;
Winchester, GA ;
Staas, JK ;
Quenelle, DC ;
Barrow, WW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2682-2689
[3]   LYSOZYME FILM HYDRATION EVENTS - IR AND GRAVIMETRIC STUDY [J].
CARERI, G ;
GIANSANTI, A ;
GRATTON, E .
BIOPOLYMERS, 1979, 18 (05) :1187-1203
[4]   A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol [J].
Cheng, YH ;
Illum, L ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1998, 55 (2-3) :203-212
[5]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[6]  
CONTI B, 1992, J MICROENCAPSUL, V9, P153
[7]   NASAL ABSORPTION OF DESMOPRESSIN IN RATS AND SHEEP - EFFECT OF A BIOADHESIVE MICROSPHERE DELIVERY SYSTEM [J].
CRITCHLEY, H ;
DAVIS, SS ;
FARRAJ, NF ;
ILLUM, L .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (08) :651-656
[8]   Oral delivery and fate of poly(lactic acid) microsphere-encapsulated interferon in rats [J].
Eyles, JE ;
Alpar, HO ;
Conway, BR ;
Keswick, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (07) :669-674
[9]   The stabilization and encapsulation of human growth hormone into biodegradable microspheres [J].
Johnson, OL ;
Jaworowicz, W ;
Cleland, JL ;
Bailey, L ;
Charnis, M ;
Duenas, E ;
Wu, CC ;
Shepard, D ;
Magil, S ;
Last, T ;
Jones, AJS ;
Putney, SD .
PHARMACEUTICAL RESEARCH, 1997, 14 (06) :730-735
[10]  
KITE FE, 1971, Patent No. 3578498